Merck | MRK - Operating Profit


Merck reported EUR1.05B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Adidas EUR 705M 541M Mar/2026
Adyen EUR 627.12M 144.33M Dec/2025
Akzo Nobel EUR 254M 37M Mar/2026
Alcon AG USD 297M 16M Mar/2026
Amadeus IT EUR 491.1M 152.2M Mar/2026
Amarin USD -2.26M 564K Dec/2025
AstraZeneca USD 7.11B 4.14B Mar/2026
BASF EUR 1.4B 1.58B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Danone EUR 1.86B 48M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Genmab DKK 260M 199M Dec/2025
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 26.38M Mar/2026
Henkel EUR 1.42B 187M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Infineon EUR 486M 98M Mar/2026
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Linde USD 2.38B 129M Mar/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Philips EUR 302M 417M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
UCB EUR 1.29B 571M Dec/2025